Blocking Galectin-3: A Powerful Strategy for Neurodegeneration and Chronic Disease
Over the last decade or so, research interest in the pro-inflammatory and pro-fibrotic immune protein galectin-3 (Gal-3) has skyrocketed. Today, thousands of published scientific papers—including longitudinal cohort studies—point to the driving role of galectin-3 in the pathogenesis of our most serious degenerative conditions, from chronic kidney disease and acute kidneyRead